Second registration trial of tenapanor to treat hyperphosphatemia
Phase of Trial: Phase III
Latest Information Update: 09 Aug 2017
At a glance
- Drugs Tenapanor (Primary)
- Indications Hyperphosphataemia
- Focus Registrational; Therapeutic Use
- Sponsors Ardelyx
- 09 Aug 2017 According to an Ardelyx media release, the company expects to begin patient enrollment by October of 2017.
- 17 Feb 2017 According to an Ardelyx media release, company is planning to initiate this trial by mid-year 2017.
- 08 Aug 2016 According to an Ardelyx media release, this trial is expected to initiate in the first half of 2017.